Molecular design of radiocopper-labelled Affibody molecules View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-04-25

AUTHORS

Vladimir Tolmachev, Tove J. Grönroos, Cheng-Bin Yim, Javad Garousi, Ying Yue, Sebastian Grimm, Johan Rajander, Anna Perols, Merja Haaparanta-Solin, Olof Solin, Riccardo Ferdani, Anna Orlova, Carolyn J. Anderson, Amelie Eriksson Karlström

ABSTRACT

The use of long-lived positron emitters 64Cu or 61Cu for labelling of Affibody molecules may improve breast cancer patients’ stratification for HER-targeted therapy. Previous animal studies have shown that the use of triaza chelators for 64Cu labelling of synthetic Affibody molecules is suboptimal. In this study, we tested a hypothesis that the use of cross-bridged chelator, CB-TE2A, in combination with Gly-Glu-Glu-Glu spacer for labelling of Affibody molecules with radiocopper would improve imaging contrast. CB-TE2A was coupled to the N-terminus of synthetic Affibody molecules extended either with a glycine (designation CB-TE2A-G-ZHER2:342) or Gly-Glu-Glu-Glu spacer (CB-TE2A-GEEE-ZHER2:342). Biodistribution and targeting properties of 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-CB-TE2A-GEEE-ZHER2:342 were compared in tumor-bearing mice with the properties of 64Cu-NODAGA-ZHER2:S1, which had the best targeting properties in the previous study. 64Cu-CB-TE2A-GEEE-ZHER2:342 provided appreciably lower uptake in normal tissues and higher tumor-to-organ ratios than 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-NODAGA-ZHER2:S1. The most pronounced was a several-fold difference in the hepatic uptake. At the optimal time point, 6 h after injection, the tumor uptake of 64Cu-CB-TE2A-GEEE-ZHER2:342 was 16 ± 6%ID/g and tumor-to-blood ratio was 181 ± 52. In conclusion, a combination of the cross-bridged CB-TE2A chelator and Gly-Glu-Glu-Glu spacer is preferable for radiocopper labelling of Affibody molecules and, possibly, other scaffold proteins having high renal re-absorption. More... »

PAGES

6542

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41598-018-24785-2

DOI

http://dx.doi.org/10.1038/s41598-018-24785-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103549305

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29695813


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tolmachev", 
        "givenName": "Vladimir", 
        "id": "sg:person.01213107367.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213107367.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "MediCity Research Laboratory, University of Turku, Turku, Finland", 
            "Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gr\u00f6nroos", 
        "givenName": "Tove J.", 
        "id": "sg:person.01102756462.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102756462.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, \u00c5bo Akademi University, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "Turku PET Centre, \u00c5bo Akademi University, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yim", 
        "givenName": "Cheng-Bin", 
        "id": "sg:person.01304157074.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304157074.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garousi", 
        "givenName": "Javad", 
        "id": "sg:person.01037636034.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037636034.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.5037.1", 
          "name": [
            "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yue", 
        "givenName": "Ying", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.5037.1", 
          "name": [
            "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grimm", 
        "givenName": "Sebastian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, \u00c5bo Akademi University, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, \u00c5bo Akademi University, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rajander", 
        "givenName": "Johan", 
        "id": "sg:person.01302045506.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302045506.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.5037.1", 
          "name": [
            "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perols", 
        "givenName": "Anna", 
        "id": "sg:person.0615410425.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615410425.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry, University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "Department of Chemistry, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haaparanta-Solin", 
        "givenName": "Merja", 
        "id": "sg:person.01313244424.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313244424.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Chemistry, University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Turku PET Centre, University of Turku, Turku, Finland", 
            "Turku PET Centre, \u00c5bo Akademi University, Turku, Finland", 
            "Department of Chemistry, University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solin", 
        "givenName": "Olof", 
        "id": "sg:person.0656631675.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Washington University, St. Louis, MO, USA", 
          "id": "http://www.grid.ac/institutes/grid.4367.6", 
          "name": [
            "Washington University, St. Louis, MO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferdani", 
        "givenName": "Riccardo", 
        "id": "sg:person.01365265771.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365265771.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Orlova", 
        "givenName": "Anna", 
        "id": "sg:person.012533763400.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012533763400.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Medicine, Radiology, Bioengineering and Pharmacology & Chemical Biology, University of Pittsburgh, 15203, Pittsburgh, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.21925.3d", 
          "name": [
            "Departments of Medicine, Radiology, Bioengineering and Pharmacology & Chemical Biology, University of Pittsburgh, 15203, Pittsburgh, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Carolyn J.", 
        "id": "sg:person.014061476732.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014061476732.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden", 
          "id": "http://www.grid.ac/institutes/grid.5037.1", 
          "name": [
            "Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karlstr\u00f6m", 
        "givenName": "Amelie Eriksson", 
        "id": "sg:person.01233273454.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233273454.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-011-1992-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035447807", 
          "https://doi.org/10.1007/s00259-011-1992-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-61779-921-1_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020088453", 
          "https://doi.org/10.1007/978-1-61779-921-1_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1367-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025550546", 
          "https://doi.org/10.1007/s00259-009-1367-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11307-013-0717-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037270557", 
          "https://doi.org/10.1007/s11307-013-0717-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2940-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019603507", 
          "https://doi.org/10.1007/s00259-014-2940-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-009-1283-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024616704", 
          "https://doi.org/10.1007/s00259-009-1283-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-04-25", 
    "datePublishedReg": "2018-04-25", 
    "description": "The use of long-lived positron emitters 64Cu or 61Cu for labelling of Affibody molecules may improve breast cancer patients\u2019 stratification for HER-targeted therapy. Previous animal studies have shown that the use of triaza chelators for 64Cu labelling of synthetic Affibody molecules is suboptimal. In this study, we tested a hypothesis that the use of cross-bridged chelator, CB-TE2A, in combination with Gly-Glu-Glu-Glu spacer for labelling of Affibody molecules with radiocopper would improve imaging contrast. CB-TE2A was coupled to the N-terminus of synthetic Affibody molecules extended either with a glycine (designation CB-TE2A-G-ZHER2:342) or Gly-Glu-Glu-Glu spacer (CB-TE2A-GEEE-ZHER2:342). Biodistribution and targeting properties of 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-CB-TE2A-GEEE-ZHER2:342 were compared in tumor-bearing mice with the properties of 64Cu-NODAGA-ZHER2:S1, which had the best targeting properties in the previous study. 64Cu-CB-TE2A-GEEE-ZHER2:342 provided appreciably lower uptake in normal tissues and higher tumor-to-organ ratios than 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-NODAGA-ZHER2:S1. The most pronounced was a several-fold difference in the hepatic uptake. At the optimal time point, 6\u2009h after injection, the tumor uptake of 64Cu-CB-TE2A-GEEE-ZHER2:342 was 16\u2009\u00b1\u20096%ID/g and tumor-to-blood ratio was 181\u2009\u00b1\u200952. In conclusion, a combination of the cross-bridged CB-TE2A chelator and Gly-Glu-Glu-Glu spacer is preferable for radiocopper labelling of Affibody molecules and, possibly, other scaffold proteins having high renal re-absorption.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41598-018-24785-2", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7122877", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7102701", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7114193", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1045337", 
        "issn": [
          "2045-2322"
        ], 
        "name": "Scientific Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "Synthetic Affibody Molecules", 
      "Affibody molecules", 
      "breast cancer patients", 
      "previous animal studies", 
      "tumor-bearing mice", 
      "optimal time point", 
      "cancer patients", 
      "CB-TE2A", 
      "blood ratio", 
      "organ ratios", 
      "animal studies", 
      "high tumor", 
      "tumor uptake", 
      "hepatic uptake", 
      "Gly-Glu", 
      "normal tissues", 
      "time points", 
      "low uptake", 
      "tumors", 
      "ZHER2", 
      "fold difference", 
      "TE2A", 
      "chelators", 
      "uptake", 
      "previous studies", 
      "patients", 
      "therapy", 
      "labeling", 
      "mice", 
      "study", 
      "biodistribution", 
      "injection", 
      "tissue", 
      "scaffold protein", 
      "conclusion", 
      "use", 
      "radiocopper", 
      "stratification", 
      "combination", 
      "S1", 
      "differences", 
      "protein", 
      "N-terminus", 
      "ratio", 
      "molecules", 
      "contrast", 
      "hypothesis", 
      "spacer", 
      "point", 
      "design", 
      "properties", 
      "molecular design", 
      "positrons"
    ], 
    "name": "Molecular design of radiocopper-labelled Affibody molecules", 
    "pagination": "6542", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103549305"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41598-018-24785-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29695813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41598-018-24785-2", 
      "https://app.dimensions.ai/details/publication/pub.1103549305"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_772.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41598-018-24785-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-24785-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-24785-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-24785-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41598-018-24785-2'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      21 PREDICATES      84 URIs      70 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41598-018-24785-2 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N9630b115cd8d4b9e90606a799a8af26a
4 schema:citation sg:pub.10.1007/978-1-61779-921-1_7
5 sg:pub.10.1007/s00259-009-1283-x
6 sg:pub.10.1007/s00259-009-1367-7
7 sg:pub.10.1007/s00259-011-1992-9
8 sg:pub.10.1007/s00259-014-2940-2
9 sg:pub.10.1007/s11307-013-0717-9
10 schema:datePublished 2018-04-25
11 schema:datePublishedReg 2018-04-25
12 schema:description The use of long-lived positron emitters 64Cu or 61Cu for labelling of Affibody molecules may improve breast cancer patients’ stratification for HER-targeted therapy. Previous animal studies have shown that the use of triaza chelators for 64Cu labelling of synthetic Affibody molecules is suboptimal. In this study, we tested a hypothesis that the use of cross-bridged chelator, CB-TE2A, in combination with Gly-Glu-Glu-Glu spacer for labelling of Affibody molecules with radiocopper would improve imaging contrast. CB-TE2A was coupled to the N-terminus of synthetic Affibody molecules extended either with a glycine (designation CB-TE2A-G-ZHER2:342) or Gly-Glu-Glu-Glu spacer (CB-TE2A-GEEE-ZHER2:342). Biodistribution and targeting properties of 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-CB-TE2A-GEEE-ZHER2:342 were compared in tumor-bearing mice with the properties of 64Cu-NODAGA-ZHER2:S1, which had the best targeting properties in the previous study. 64Cu-CB-TE2A-GEEE-ZHER2:342 provided appreciably lower uptake in normal tissues and higher tumor-to-organ ratios than 64Cu-CB-TE2A-G-ZHER2:342 and 64Cu-NODAGA-ZHER2:S1. The most pronounced was a several-fold difference in the hepatic uptake. At the optimal time point, 6 h after injection, the tumor uptake of 64Cu-CB-TE2A-GEEE-ZHER2:342 was 16 ± 6%ID/g and tumor-to-blood ratio was 181 ± 52. In conclusion, a combination of the cross-bridged CB-TE2A chelator and Gly-Glu-Glu-Glu spacer is preferable for radiocopper labelling of Affibody molecules and, possibly, other scaffold proteins having high renal re-absorption.
13 schema:genre article
14 schema:isAccessibleForFree true
15 schema:isPartOf N3f4d4013208b464081c14b0056a80026
16 N79cee9beeab946738bfddd71cd454e45
17 sg:journal.1045337
18 schema:keywords Affibody molecules
19 CB-TE2A
20 Gly-Glu
21 N-terminus
22 S1
23 Synthetic Affibody Molecules
24 TE2A
25 ZHER2
26 animal studies
27 biodistribution
28 blood ratio
29 breast cancer patients
30 cancer patients
31 chelators
32 combination
33 conclusion
34 contrast
35 design
36 differences
37 fold difference
38 hepatic uptake
39 high tumor
40 hypothesis
41 injection
42 labeling
43 low uptake
44 mice
45 molecular design
46 molecules
47 normal tissues
48 optimal time point
49 organ ratios
50 patients
51 point
52 positrons
53 previous animal studies
54 previous studies
55 properties
56 protein
57 radiocopper
58 ratio
59 scaffold protein
60 spacer
61 stratification
62 study
63 therapy
64 time points
65 tissue
66 tumor uptake
67 tumor-bearing mice
68 tumors
69 uptake
70 use
71 schema:name Molecular design of radiocopper-labelled Affibody molecules
72 schema:pagination 6542
73 schema:productId N379f6d6d29f6476c8160b5dd7189a516
74 N70b0455026764310b1f88c3bac604926
75 Na859318fce6148f786425dde258bd0de
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103549305
77 https://doi.org/10.1038/s41598-018-24785-2
78 schema:sdDatePublished 2022-09-02T16:02
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N98ab9b8b034c4cb293a8bfb1a98fd84c
81 schema:url https://doi.org/10.1038/s41598-018-24785-2
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N006b0395fa1c4a648e3954c15e2ad0a3 rdf:first sg:person.0656631675.01
86 rdf:rest Ne532fbb87d7146dc8391e2ba09577015
87 N048e6c21a25049f08088bea0989fbe62 schema:affiliation grid-institutes:grid.5037.1
88 schema:familyName Grimm
89 schema:givenName Sebastian
90 rdf:type schema:Person
91 N05dcd91379a7432aaeda8344a5b6fefa rdf:first sg:person.014061476732.89
92 rdf:rest N4f1fd5b6e0414d6e9b76a72fbda7c19c
93 N189fbc0d2df14afe8c4b1a58c952d661 rdf:first sg:person.01302045506.03
94 rdf:rest Ndeb7a02b377f4c618d69ecba6d0691e7
95 N379f6d6d29f6476c8160b5dd7189a516 schema:name dimensions_id
96 schema:value pub.1103549305
97 rdf:type schema:PropertyValue
98 N3f4d4013208b464081c14b0056a80026 schema:volumeNumber 8
99 rdf:type schema:PublicationVolume
100 N4e523a200bde4e1dbf73cffe1303dd1f rdf:first sg:person.01313244424.19
101 rdf:rest N006b0395fa1c4a648e3954c15e2ad0a3
102 N4f1fd5b6e0414d6e9b76a72fbda7c19c rdf:first sg:person.01233273454.70
103 rdf:rest rdf:nil
104 N70b0455026764310b1f88c3bac604926 schema:name pubmed_id
105 schema:value 29695813
106 rdf:type schema:PropertyValue
107 N79cee9beeab946738bfddd71cd454e45 schema:issueNumber 1
108 rdf:type schema:PublicationIssue
109 N7deb63198af147bdae9f8e7ccecc9252 rdf:first sg:person.012533763400.14
110 rdf:rest N05dcd91379a7432aaeda8344a5b6fefa
111 N8feaa36ca501456c9aa16cbcd1c6aea0 rdf:first Nbbde9d40a7b145aa95a3fc983ecb1e2e
112 rdf:rest Nadd303293d6d4cc49eaf438bcf018f8a
113 N94017b43060e4cabbd8171d524b47908 rdf:first sg:person.01304157074.80
114 rdf:rest Nb109725f3ddc48e89ac7627582e55d7d
115 N9630b115cd8d4b9e90606a799a8af26a rdf:first sg:person.01213107367.17
116 rdf:rest Nab9b840875204d41a713d54ef0b8c650
117 N98ab9b8b034c4cb293a8bfb1a98fd84c schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 Na859318fce6148f786425dde258bd0de schema:name doi
120 schema:value 10.1038/s41598-018-24785-2
121 rdf:type schema:PropertyValue
122 Nab9b840875204d41a713d54ef0b8c650 rdf:first sg:person.01102756462.43
123 rdf:rest N94017b43060e4cabbd8171d524b47908
124 Nadd303293d6d4cc49eaf438bcf018f8a rdf:first N048e6c21a25049f08088bea0989fbe62
125 rdf:rest N189fbc0d2df14afe8c4b1a58c952d661
126 Nb109725f3ddc48e89ac7627582e55d7d rdf:first sg:person.01037636034.95
127 rdf:rest N8feaa36ca501456c9aa16cbcd1c6aea0
128 Nbbde9d40a7b145aa95a3fc983ecb1e2e schema:affiliation grid-institutes:grid.5037.1
129 schema:familyName Yue
130 schema:givenName Ying
131 rdf:type schema:Person
132 Ndeb7a02b377f4c618d69ecba6d0691e7 rdf:first sg:person.0615410425.90
133 rdf:rest N4e523a200bde4e1dbf73cffe1303dd1f
134 Ne532fbb87d7146dc8391e2ba09577015 rdf:first sg:person.01365265771.54
135 rdf:rest N7deb63198af147bdae9f8e7ccecc9252
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
140 schema:name Oncology and Carcinogenesis
141 rdf:type schema:DefinedTerm
142 sg:grant.7102701 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-24785-2
143 rdf:type schema:MonetaryGrant
144 sg:grant.7114193 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-24785-2
145 rdf:type schema:MonetaryGrant
146 sg:grant.7122877 http://pending.schema.org/fundedItem sg:pub.10.1038/s41598-018-24785-2
147 rdf:type schema:MonetaryGrant
148 sg:journal.1045337 schema:issn 2045-2322
149 schema:name Scientific Reports
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01037636034.95 schema:affiliation grid-institutes:grid.8993.b
153 schema:familyName Garousi
154 schema:givenName Javad
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037636034.95
156 rdf:type schema:Person
157 sg:person.01102756462.43 schema:affiliation grid-institutes:grid.410552.7
158 schema:familyName Grönroos
159 schema:givenName Tove J.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102756462.43
161 rdf:type schema:Person
162 sg:person.01213107367.17 schema:affiliation grid-institutes:grid.8993.b
163 schema:familyName Tolmachev
164 schema:givenName Vladimir
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213107367.17
166 rdf:type schema:Person
167 sg:person.01233273454.70 schema:affiliation grid-institutes:grid.5037.1
168 schema:familyName Karlström
169 schema:givenName Amelie Eriksson
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233273454.70
171 rdf:type schema:Person
172 sg:person.012533763400.14 schema:affiliation grid-institutes:grid.8993.b
173 schema:familyName Orlova
174 schema:givenName Anna
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012533763400.14
176 rdf:type schema:Person
177 sg:person.01302045506.03 schema:affiliation grid-institutes:grid.470895.7
178 schema:familyName Rajander
179 schema:givenName Johan
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302045506.03
181 rdf:type schema:Person
182 sg:person.01304157074.80 schema:affiliation grid-institutes:grid.470895.7
183 schema:familyName Yim
184 schema:givenName Cheng-Bin
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304157074.80
186 rdf:type schema:Person
187 sg:person.01313244424.19 schema:affiliation grid-institutes:grid.1374.1
188 schema:familyName Haaparanta-Solin
189 schema:givenName Merja
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313244424.19
191 rdf:type schema:Person
192 sg:person.01365265771.54 schema:affiliation grid-institutes:grid.4367.6
193 schema:familyName Ferdani
194 schema:givenName Riccardo
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365265771.54
196 rdf:type schema:Person
197 sg:person.014061476732.89 schema:affiliation grid-institutes:grid.21925.3d
198 schema:familyName Anderson
199 schema:givenName Carolyn J.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014061476732.89
201 rdf:type schema:Person
202 sg:person.0615410425.90 schema:affiliation grid-institutes:grid.5037.1
203 schema:familyName Perols
204 schema:givenName Anna
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0615410425.90
206 rdf:type schema:Person
207 sg:person.0656631675.01 schema:affiliation grid-institutes:grid.1374.1
208 schema:familyName Solin
209 schema:givenName Olof
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656631675.01
211 rdf:type schema:Person
212 sg:pub.10.1007/978-1-61779-921-1_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020088453
213 https://doi.org/10.1007/978-1-61779-921-1_7
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s00259-009-1283-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024616704
216 https://doi.org/10.1007/s00259-009-1283-x
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s00259-009-1367-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025550546
219 https://doi.org/10.1007/s00259-009-1367-7
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/s00259-011-1992-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035447807
222 https://doi.org/10.1007/s00259-011-1992-9
223 rdf:type schema:CreativeWork
224 sg:pub.10.1007/s00259-014-2940-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019603507
225 https://doi.org/10.1007/s00259-014-2940-2
226 rdf:type schema:CreativeWork
227 sg:pub.10.1007/s11307-013-0717-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037270557
228 https://doi.org/10.1007/s11307-013-0717-9
229 rdf:type schema:CreativeWork
230 grid-institutes:grid.1374.1 schema:alternateName Department of Chemistry, University of Turku, Turku, Finland
231 schema:name Department of Chemistry, University of Turku, Turku, Finland
232 Turku PET Centre, University of Turku, Turku, Finland
233 Turku PET Centre, Åbo Akademi University, Turku, Finland
234 rdf:type schema:Organization
235 grid-institutes:grid.21925.3d schema:alternateName Departments of Medicine, Radiology, Bioengineering and Pharmacology & Chemical Biology, University of Pittsburgh, 15203, Pittsburgh, PA, USA
236 schema:name Departments of Medicine, Radiology, Bioengineering and Pharmacology & Chemical Biology, University of Pittsburgh, 15203, Pittsburgh, PA, USA
237 rdf:type schema:Organization
238 grid-institutes:grid.410552.7 schema:alternateName Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland
239 schema:name Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland
240 MediCity Research Laboratory, University of Turku, Turku, Finland
241 Turku PET Centre, University of Turku, Turku, Finland
242 rdf:type schema:Organization
243 grid-institutes:grid.4367.6 schema:alternateName Washington University, St. Louis, MO, USA
244 schema:name Washington University, St. Louis, MO, USA
245 rdf:type schema:Organization
246 grid-institutes:grid.470895.7 schema:alternateName Turku PET Centre, Åbo Akademi University, Turku, Finland
247 schema:name Turku PET Centre, University of Turku, Turku, Finland
248 Turku PET Centre, Åbo Akademi University, Turku, Finland
249 rdf:type schema:Organization
250 grid-institutes:grid.5037.1 schema:alternateName Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
251 schema:name Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden
252 rdf:type schema:Organization
253 grid-institutes:grid.8993.b schema:alternateName Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
254 Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden
255 schema:name Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
256 Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...